Biological Stock: Subsidiary obtains the new animal drug registration certificate for the goose Newcastle disease and duck plague bivalent inactivated vaccine.

The announcement of the biological company stated that the goose and gosling immunization vaccine jointly developed by its wholly-owned subsidiary, Jinyu Ubang Biological Technology Co., Ltd., and other units has been approved by the Ministry of Agriculture and Rural Affairs as a new animal drug, with the registration certificate number as New Animal Drug Certificate No. 44. This vaccine is used to prevent Newcastle disease and gosling plague, with a immunity production period of 21 days after two immunizations for adult geese, a immunity period of 5 months, and a passive immunity period of 20 days for goslings. Before the product is launched, an application for the approval number of the veterinary drug product must be submitted. Once approved, it will enrich the company's vaccine matrix for waterfowl and enhance its market competitiveness.